Cleared Traditional

K042657 - VIOPTIX ODISSEY TISSUE OXIMETER TISSUE OXIMETER, MODEL OXY-2 (FDA 510(k) Clearance)

Jan 2005
Decision
104d
Days
Class 2
Risk

K042657 is an FDA 510(k) clearance for the VIOPTIX ODISSEY TISSUE OXIMETER TISSUE OXIMETER, MODEL OXY-2. This device is classified as a Oximeter, Tissue Saturation (Class II - Special Controls, product code MUD).

Submitted by Vioptix, Inc. (Irvine, US). The FDA issued a Cleared decision on January 10, 2005, 104 days after receiving the submission on September 28, 2004.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2700.

Submission Details

510(k) Number K042657 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2004
Decision Date January 10, 2005
Days to Decision 104 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MUD - Oximeter, Tissue Saturation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2700

Similar Devices - MUD Oximeter, Tissue Saturation

Masimo O3 Regional Oximeter
K243324 · Masimo Corporation · Jul 2025
Edwards Algorithm for Measurement of Blood Hemoglobin
K230612 · Edwards Lifesciences, LLC · Nov 2023
Cerebral Adaptive Index (CAI) Algorithm
K223651 · Edwards Lifesciences, LLC · May 2023
Masimo O3 Regional Oximeter System
K214072 · Masimo Corporation · May 2022
INVOS PM7100 Patient Monitor, INVOS Pediatric rSO2 Sensor, INVOS Infant Regional Saturation Sensor (also referred to as OxyAlert NIRSensor)
K211561 · Covidien, LLC · Dec 2021
FORE-SIGHT ELITE Absolute Tissue Oximeter
K203490 · Edwards Lifesciences, LLC · Feb 2021